🔎 Trials Near Me

ホーム › COPD › ペンシルベニア › Philadelphia

Philadelphia、PAにおけるCOPDの臨床試験

Philadelphiaとその周辺地域(約30マイル以内)の拠点で、COPDに関する23件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

被験者募集中第3相
  • Research Site, Philadelphia
  • Research Site, Philadelphia
40歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

被験者募集中第3相
  • Suburban Research Associates - Media- Site Number : 8400143, Media · 12マイル先
40歳〜80歳 · 全性別 · 2026/10/01更新 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

被験者募集中第2相
  • DM Clinical Research - Philadelphia, Philadelphia
40歳〜85歳 · 全性別 · 2026/09/30更新 · NCT07684820

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

被験者募集中第3相
  • Temple University Hospital- Site Number : 8400059, Philadelphia
40歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

被験者募集中
  • Penn Medicine, Philadelphia
  • Temple University, Philadelphia
40歳〜80歳 · 全性別 · 2026/09/17更新 · NCT06035120

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

被験者募集中第2相
  • Research Site, Philadelphia
  • Research Site, Philadelphia
40歳以上 · 全性別 · 2026/09/09更新 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

被験者募集中第2相
  • Temple University, Philadelphia
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

被験者募集中第3相
  • Research Site, Horsham · 16マイル先
  • Research Site, Wilmington · 25マイル先
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

被験者募集中第3相
  • Research Site, Philadelphia
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06883305

COPD Exacerbation Follow Up

被験者募集中観察研究
  • Thomas Jefferson University, Philadelphia
40歳以上 · 全性別 · 2026/09/02更新 · NCT07118306

STRIVE Post-Market Registry Study

被験者募集中観察研究
  • Temple University, Philadelphia
18歳以上 · 全性別 · 2026/08/03更新 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

被験者募集中第3相
  • GSK Investigational Site, West Chester · 24マイル先
40歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07177339

Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

被験者募集中
  • Temple University Hospital, Philadelphia
22歳以上 · 全性別 · 2026/06/23更新 · NCT07222410

SPIROMICS Study of Early COPD Progression (SOURCE)

被験者募集中観察研究健康なボランティア歓迎
  • Temple University, Philadelphia
30歳〜55歳 · 全性別 · 2026/06/03更新 · NCT05033990

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

被験者募集中
  • Temple University - Temple Lung Center, Philadelphia
40歳〜80歳 · 全性別 · 2026/04/28更新 · NCT07051707

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

被験者募集中
  • Temple University, Philadelphia
40歳〜84歳 · 全性別 · 2026/04/24更新 · NCT06891755

Feasibility of Semaglutide in Advanced Lung Disease

被験者募集中第1/2相
  • University of Pennsylvania Perelman School of Medicine, Philadelphia
18歳〜80歳 · 全性別 · 2026/04/21更新 · NCT05746039

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

被験者募集中第3相
  • GSK Investigational Site, Philadelphia
40歳〜80歳 · 全性別 · 2026/04/09更新 · NCT06961214

Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

被験者募集中観察研究
  • Thomas Jefferson University, Philadelphia
50歳〜80歳 · 全性別 · 2026/03/03更新 · NCT06974981

Supporting Evidence-based Responses to Emotional Needs in Emphysema

被験者募集中
  • University of Pennsylvania, Philadelphia
18歳以上 · 全性別 · 2026/01/30更新 · NCT06600126

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

被験者募集中観察研究
  • Temple University, Philadelphia
50歳以上 · 全性別 · 2025/08/05更新 · NCT06122077

Temple Health Chest Initiative (THCI 2.0)

被験者募集中観察研究健康なボランティア歓迎
  • Temple University Of the Commonwealth System of Higher Education, Philadelphia
50歳〜80歳 · 全性別 · 2025/04/18更新 · NCT06933758

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

被験者募集中
  • Jeanes Hospital, Philadelphia
  • Temple University, Philadelphia
30歳以上 · 全性別 · 2025/02/06更新 · NCT05204888

他の都市におけるCOPDの試験

Philadelphiaにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。